Johnson & Johnson Loses Key TB Drug Patent in India
GG News Bureau
New Delhi, 24th March. The Indian Patent Office rejected Johnson & Johnson's application to extend its patent on a key tuberculosis treatment on Thursday, allowing local companies to produce cheaper generic versions.…